SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines

BACKGROUND: Development of a universal cancer vaccine for the prevention of all cancers has been under development for many years. Antiangiogenic cancer vaccines elicit immune responses with the potential of destroying tumor vasculature endothelial cells without affecting vasculature integrity in no...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokhov, Petr G., Balashova, Elena E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396256/
https://www.ncbi.nlm.nih.gov/pubmed/27903220
http://dx.doi.org/10.2174/1872208309666161130140535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396256/
https://www.ncbi.nlm.nih.gov/pubmed/27903220
http://dx.doi.org/10.2174/1872208309666161130140535

Ejemplares similares